Lung Cancer & Staging
- Lung cancer is the leading cause of cancer death, and imaging does three jobs: find it, stage it, and watch it.
- Staging answers one question — how far has it traveled? — using the TNM system: the Tumor itself, the Nodes, and distant Metastasis.
- CT of the chest (and upper abdomen) is the workhorse; FDG-PET/CT adds whether tissue is metabolically "hot," which catches spread that anatomy alone misses.
- Brain MRI is the go-to once disease looks more than minimal, because the brain is a favorite vacation spot for lung cancer and CT can be too polite to mention small metastases.
- Stage is the single biggest driver of treatment and prognosis — earlier stage, more curable.
Lung cancer is the disease that turned the chest X-ray into a high-stakes hidden-object puzzle. A smudge that's "probably nothing" sometimes isn't, and the entire job of imaging is to figure out, calmly and systematically, exactly how much trouble we're in. The trouble word is staging, and once you understand it, half of chest oncology stops feeling like alphabet soup.
First, what are we even looking at?
Most lung cancers announce themselves as a mass or a stubborn area of consolidation that won't clear, but plenty start life as a quiet solitary pulmonary nodule that someone wisely refused to ignore. The radiologist's instinct is to be suspicious of anything spiculated (spiky, like it's putting down roots), growing over time, or hanging out in a smoker's upper lobe.
There are two big buckets clinically: non-small cell lung cancer (NSCLC), the common one that staging was largely built around, and small cell lung cancer (SCLC), which is aggressive, usually central, and tends to have already spread by the time we meet it. Imaging looks broadly similar; what differs is how fast the story moves.
Staging in one breath: how far has it traveled?
Here's the mental model. Imagine the tumor as an unwelcome houseguest. Staging is just asking how far they've wandered through the house. Are they confined to one room (the lung)? Have they reached the hallway (the lymph nodes)? Or have they let themselves into the neighbor's place entirely (distant organs)? That's literally the TNM system, the universal language of cancer described in staging principles & TNM.
| Letter | The question | Roughly what imaging looks for |
|---|---|---|
| T | How big and how invasive is the primary tumor? | Size, plus invasion of pleura, chest wall, mediastinum, diaphragm, or major vessels. |
| N | Which lymph nodes are involved, and where? | Hilar and mediastinal nodes — and crucially, which side they're on. |
| M | Has it spread to distant sites? | Other lung, pleura, adrenals, liver, bone, brain. |
The reason N is such a big deal: nodes on the same side as the tumor are a smaller problem than nodes that have crossed the midline to the opposite side, which signals more advanced disease. Direction of travel matters as much as distance.
The toolkit, and why each tool exists
The reason we don't just take one picture and call it a day is that no single study sees everything. Each modality has a personality.
| Study | What it's great at | The catch |
|---|---|---|
| Chest CT (with contrast, through the upper abdomen) | The anatomic map — tumor size, invasion, node size, liver and adrenal mets | Size alone can't tell a busy node from a cancerous one |
| FDG-PET/CT | Showing which tissue is metabolically hot — flags involved nodes and unexpected mets | Infection and inflammation light up too (false positives) |
| Brain MRI | The most sensitive look for brain metastases | Doesn't help with the chest itself |
FDG-PET in oncology deserves special love here. CT measures how big a node is; PET measures how active it is. A normal-sized node that's glowing is more worrying than a chunky one that's quiet. That complementary view is why the two are fused into a single PET/CT study.
Whenever you see lung cancer staging imaging, mentally extend your gaze below the lungs. The scan deliberately includes the adrenal glands and liver because they're common, easy-to-miss landing spots for metastases.
Why all this effort matters
Stage is the number that decides nearly everything. Loosely: when cancer is confined and the lymph nodes are clean, surgery aimed at cure is on the table. As nodes get involved — especially across the midline — treatment shifts toward chemotherapy and radiation. And once there's distant spread, the strategy becomes controlling the disease rather than removing it. Same tumor under the microscope, wildly different roads, decided largely by what we see on imaging.
A "met" on imaging isn't always a met. A single adrenal nodule, a lone hot spot, or one enlarged node can be a benign mimic — a sleepy adrenal adenoma, an infection lighting up on PET, or a reactive node. Because this distinction can change someone's whole treatment plan, a solitary suspicious finding often gets confirmed with tissue (biopsy) before anyone commits to a stage.
The one thing to remember
Lung cancer imaging isn't about one heroic picture. It's a coordinated answer to a single question — how far has it traveled? — built from CT for the map, PET for the metabolic truth, and brain MRI for the one organ everything else underestimates. Get the stage right, and the right treatment usually follows.